BIOCUREX
Richmond Hill
About BIOCUREX
Biocurex, Inc. is a development-stage company. The Company is focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. The Company has developed a blood test that can detect the presence of cancer in humans and animals using a cancer marker named RECAF. The Company developed and own, royalty-free, the technology related to the RECAF marker. RECAF is a molecule found on cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells. RECAF can be used in blood tests to determine if a patient has cancer. The Company has developed prototype RECAF test kits and materials for small laboratories. Biocurex China Co., Ltd. is the Company's subsidiary.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.1M
- Last round: Debt Financing (Aug 2009)
- Website: biocurex.com
Industries & Categories
Biotechnology, Developer Platform, Health Diagnostics
Canonical: https://fsome.com/organization/biocurex-687186 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.